Hematology and Oncology Book

Coagulopathy

Anemia

Cancer

Platelet Disorders

Hemoglobinopathies

Hemolytic Disorders

Pathology and Laboratory Medicine

Lymphatic Disorders

Blood Transfusion

Tranfusion

Obstetrics Chapter related topics

//fpnotebook.com/

Enoxaparin

Aka: Enoxaparin, Lovenox
  1. See Also
    1. Low Molecular Weight Heparin (LMWH)
  2. Dosing: Prophylactic Dose
    1. Creatinine Clearance (CrCl) >30 ml/min AND Weight 40-150 kg
      1. Enoxaparin (Lovenox) 40 mg SQ daily
    2. Creatinine Clearance (CrCl) >30 ml/min AND Weight >150 kg (or BMI 40 of higher)
      1. Enoxaparin (Lovenox) 40 mg SQ twice daily
    3. Creatinine Clearance (CrCl) 15-30 ml/min (or weight <40 kg)
      1. Enoxaparin (Lovenox) 30 mg SQ daily
    4. Creatinine Clearance (CrCl) <15 ml/min
      1. Enoxaparin (Lovenox) is contraindicated
      2. Use unfractionated heaprin 5000 units SQ every 8-12 hours
  3. Dosing: Therapeutic Dose
    1. Creatinine Clearance (CrCl) >30 ml/min
      1. Enoxaparin (Lovenox) 1 mg/kg SQ every 12 hours
    2. Creatinine Clearance (CrCl) 15-30 ml/min (or weight <40 kg)
      1. Unfractionated Heparin is preferred
      2. As an alternative, Enoxaparin (Lovenox) 1 mg/kg SQ once daily for up to 7 days
    3. Creatinine Clearance (CrCl) <15 ml/min
      1. Enoxaparin (Lovenox) is contraindicated
      2. Use unfractionated heaprin 5000 units SQ every 8-12 hours
  4. References
    1. Dummer (2009) Perioperative Guidelines
    2. Douketis (2008) Chest 133(6 Suppl):299S-339S [PubMed]
Medication Costs
enoxaparin (on 5/17/2017 at Medicaid.Gov Pharmacy Drug pricing)
ENOXAPARIN 100 MG/ML SYRINGE Generic $12.59 per ml
ENOXAPARIN 120 MG/0.8 ML SYR Generic $20.61 per ml
ENOXAPARIN 150 MG/ML SYRINGE Generic $18.54 per ml
ENOXAPARIN 30 MG/0.3 ML SYR Generic $21.12 per ml
ENOXAPARIN 40 MG/0.4 ML SYR Generic $15.78 per ml
ENOXAPARIN 60 MG/0.6 ML SYR Generic $13.89 per ml
ENOXAPARIN 80 MG/0.8 ML SYR Generic $13.12 per ml
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Enoxaparin (C0206460)

Definition (NCI_NCI-GLOSS) A drug used to prevent blood clots. It belongs to the family of drugs called anticoagulants.
Definition (NCI) A low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, enoxaprin's mechanism of action is similar to that of heparin, although it exhibits a higher ratio of anti-Factor Xa to anti-Factor IIa activity. This agent also has anti-inflammatory properties, inhibiting monocyte adhesion to tumor necrosis factor alpha- or lipopolysaccharide-activated endothelial cells. Compared to unfractionated heparins, the use of enoxaparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia. (NCI04)
Definition (MSH) Low-molecular-weight fragment of heparin, having a 4-enopyranosuronate sodium structure at the non-reducing end of the chain. It is prepared by depolymerization of the benzylic ester of porcine mucosal heparin. Therapeutically, it is used as an antithrombotic agent. (From Merck Index, 11th ed)
Definition (PDQ) A low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, enoxaprin's mechanism of action is similar to that of heparin, although it exhibits a higher ratio of anti-Factor Xa to anti-Factor IIa activity. This agent also has anti-inflammatory properties, inhibiting monocyte adhesion to tumor necrosis factor alpha- or lipopolysaccharide-activated endothelial cells. Compared to unfractionated heparins, the use of enoxaparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=37880&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=37880&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1452" NCI Thesaurus)
Concepts Pharmacologic Substance (T121) , Carbohydrate (T118)
MSH D017984
SnomedCT 108984007, 372562003
English Enoxaparin, Enoxaparine, enoxaparin (medication), Enoxaparin [Chemical/Ingredient], enoxaparine, ENOXAPARIN, enoxaparin, Enoxaparin (product), Enoxaparin (substance)
Swedish Enoxaparin
Czech enoxaparin
Finnish Enoksapariini
Italian Enoxaparine, Enoxaparina
Russian ENOKSAPARIN, ЭНОКСАПАРИН
Japanese エノキサパリン
Polish Enoksaparyna
Croatian Enoksaparin
Spanish enoxaparina (producto), enoxaparina (sustancia), enoxaparina, Enoxaparina
French Énoxaparine
German Enoxaparin
Portuguese Enoxaparina
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Lovenox (C0728963)

Definition (CHV) brand name of enoxaparin
Definition (CHV) brand name of enoxaparin
Concepts Pharmacologic Substance (T121) , Carbohydrate (T118)
MSH D017984
English Lovenox [brand name], Lovenox
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree